Skip to main content
. 2021 Mar 25;14:1069–1084. doi: 10.2147/JIR.S296597

Figure 5.

Figure 5

Correlations between promoter methylation level of FUT7 and clinicopathological features of BLCA patients. (A) The negative correlation between the promoter methylation level of FUT7 and the expression of FUT7 in BLCA analyzed by cBioPortal database. (BF) The relative promoter methylation level of FUT7 was analyzed with UALCAN database based on sample type (B), cancer stage (C), nodal metastasis status (D), patient’s age (E), and weight (F). *P<0.05, **P<0.01, ***P<0.001.